Related Experiment Video
Updated: Jun 22, 2026
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Reovirus-based therapy for cancer.
Kevin Kelly1, Steffan Nawrocki, Alain Mita
1University of Texas Health Science Center, Institute for Drug Development, Cancer Therapy and Research Center, 7979 Wurzbach Road, San Antonio, Texas 78229, USA.
Expert Opinion on Biological Therapy
|June 17, 2009
Summary
Reovirus, an oncolytic virus, shows promise in cancer treatment by selectively targeting cancer cells. Clinical studies indicate good tolerability and encouraging anticancer activity, even in combination therapies.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- Reovirus is an oncolytic virus with a natural tropism for cancer cells, exploiting aberrant Ras signaling pathways.
- Pre-clinical research indicates significant anticancer activity of reovirus across various tumor types.
- Reolysin is a specific formulation of human reovirus being developed for therapeutic applications.
Purpose of the Study:
- To evaluate the safety and efficacy of reovirus (Reolysin) as an oncolytic cancer therapy.
- To explore the potential of reovirus in combination with standard cancer treatments.
- To investigate strategies for optimizing reovirus delivery and efficacy by modulating the immune response.
Main Methods:
- Clinical evaluation of reovirus therapy, including local and systemic administration.
- Assessment of reovirus efficacy as a single agent and in combination with chemotherapy and radiotherapy.
- Development of immunosuppressive strategies to enhance tumor penetration while maintaining safety.
Main Results:
- Reovirus therapy has demonstrated good tolerability in clinical trials.
- Encouraging anticancer efficacy has been observed with reovirus, both alone and in combination regimens.
- Phase II studies are ongoing to further assess reovirus in diverse cancer types.
Conclusions:
- Reovirus therapy presents a promising, well-tolerated approach to cancer treatment.
- Further research and development, including immune modulation strategies, may enhance reovirus's role in oncology.
- Reovirus holds potential to become an established anticancer agent due to its favorable safety and efficacy profile.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...